2024
Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
Richman I, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2024, 177: 403-404. PMID: 38498894, DOI: 10.7326/l23-0485.Peer-Reviewed Original Research
2022
Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity
Richman I, Tessier-Sherman B, Galusha D, Oladele CR, Wang K. Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity. Journal Of The National Cancer Institute 2022, 115: 139-145. PMID: 36069622, PMCID: PMC9494402, DOI: 10.1093/jnci/djac172.Peer-Reviewed Original ResearchConceptsBreast cancer screeningCancer screeningHealth systemHealth equityBreast cancer controlRoutine health careCOVID-19 pandemicCOVID-19 waveMammography ratesCancer controlMammography useMultifactorial conditionHealth disparitiesWhite womenScreening mammographyHealth careWomenCOVID-19Subsequent COVID-19 wavesLower ratesNumber of studiesMammographyDisparitiesPandemicSpecific patternsInsurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis
Richman IB, Long JB, Kyanko KA, Xu X, Gross CP, Busch SH. Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis. JAMA Network Open 2022, 5: e224208. PMID: 35333358, PMCID: PMC8956980, DOI: 10.1001/jamanetworkopen.2022.4208.Peer-Reviewed Original ResearchConceptsCoverage mandateCohort studyBreast cancerPocket paymentsDigital breast tomosynthesisInsurance coveragePoints 2 yearsAffordable Care ActMAIN OUTCOMEScreening mammogramsStudy periodDirect costsBreast tomosynthesisPatient ProtectionCare ActWomenCancerAssociationYearsPrivate insurersPatientsCost sharing
2021
Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women
Upneja A, Long JB, Aminawung JA, Kyanko KA, Kunst N, Xu X, Busch SH, Gross CP, Richman IB. Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women. Journal Of General Internal Medicine 2021, 37: 1870-1876. PMID: 34595682, PMCID: PMC8483166, DOI: 10.1007/s11606-021-07132-6.Peer-Reviewed Original ResearchConceptsWomen 75Older womenBreast cancerAdditional cancersSubsequent imagingWomen 67Stage ITime of diagnosisEarly-stage cancerHigh rateCancer detectionConclusionsBreast cancerPrior cancerPotential confoundersScreening outcomesHealth outcomesService beneficiariesComparative effectivenessScreening mammogramsAge groupsCancerLogistic regressionResultsOur studyWomenBreast tomosynthesisComparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old
Richman IB, Long JB, Hoag JR, Upneja A, Hooley R, Xu X, Kunst N, Aminawung JA, Kyanko KA, Busch SH, Gross CP. Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old. Journal Of The National Cancer Institute 2021, 113: 1515-1522. PMID: 33822120, PMCID: PMC8757313, DOI: 10.1093/jnci/djab063.Peer-Reviewed Original ResearchConceptsHigher cancer detection rateCancer detection rateBreast cancer screeningCancer screeningScreening outcomesBreast cancer screening outcomesDigital breast tomosynthesisCancer screening outcomesPopulation-level adoptionReal-world cohortMultivariable logistic regressionHigher biopsy ratesPatient-level analysisPopulation health impactDetection rateIncident cancerClinical outcomesWomen 40Biopsy rateObservational studyComparative effectivenessLogistic regressionYoung womenPrivate health insurersWomen
2020
Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
Aminawung JA, Hoag JR, Kyanko KA, Xu X, Richman IB, Busch SH, Gross CP. Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation. Cancer Medicine 2020, 9: 5662-5671. PMID: 32537899, PMCID: PMC7402830, DOI: 10.1002/cam4.3218.Peer-Reviewed Original ResearchUse and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance
Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Richman IB, Gross CP. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine 2020, 180: 799-801. PMID: 32202606, PMCID: PMC7147248, DOI: 10.1001/jamainternmed.2020.0262.Peer-Reviewed Original Research
2019
New Breast Cancer Screening Technologies in Older Women—Is It Time to Pump the Brakes?
Richman IB, Gross CP. New Breast Cancer Screening Technologies in Older Women—Is It Time to Pump the Brakes? JAMA Internal Medicine 2019, 179: 289-290. PMID: 30640376, DOI: 10.1001/jamainternmed.2018.7767.Commentaries, Editorials and Letters